Ono Pharmaceutical Co Ltd
TSE:4528
Ono Pharmaceutical Co Ltd
Net Income (Common)
Ono Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ono Pharmaceutical Co Ltd
TSE:4528
|
Net Income (Common)
¥127.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
20%
|
CAGR 10-Years
19%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥178.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥186.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥121.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥325.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥37.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
See Also
What is Ono Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
127.6B
JPY
Based on the financial report for Dec 31, 2023, Ono Pharmaceutical Co Ltd's Net Income (Common) amounts to 127.6B JPY.
What is Ono Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
19%
Over the last year, the Net Income (Common) growth was 14%. The average annual Net Income (Common) growth rates for Ono Pharmaceutical Co Ltd have been 20% over the past three years , 20% over the past five years , and 19% over the past ten years .